Navigation Links
Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis

New Data Presented at EULAR Confirms Efficacy with Either Every Two Weeksn or Monthly Dosing

BARCELONA, Spain, 14 June 2007 - 7:00 am CET - New pivotal data (RAPID 1 and RAPID 2) presented at the Annual European Congress of Rheumatology (EULAR) show that Cimzia (certolizumab pegol), the first PEGylated, Fc-free anti-TNF, combined with methotrexate therapy has a rapid and significant effect in reducing the signs and symptoms of active rheumatoid arthritis (RA) compared with methotrexate alone. Data from a third study, the 011 trial, presented at the conference also showed that Cimzia given every four weeks as monotherapy is significantly more efficacious than placebo in the treatment of patients with active RA who had previously failed
disease-modifying anti-rheumatic drug (DMARD) therapy.

In both pivotal Phase III studies, RAPID 1 and RAPID 2, the primary endpoint, ACR20[a] response at 24 weeks, was significantly higher in
both CIMZIA(TM) treated arms (400 mg at week zero, week two and week four followed by 200 mg every two weeks plus methotrexate; or 400 mg every two weeks plus methotrexate) compared with the placebo plus methotrexate-treated arm (p<0.001). In both studies there was no significant difference between response levels in either of the CIMZIA(TM) treatment arms. ACR50 and ACR70 responses were also achieved rapidly and with statistical significance in both studies in the CIMZIA(TM) treated arms.

RAPID 1 and RAPID 2 demonstrated that effective results in the treatment of RA can be achieved with a 200 mg every other week dose
of CIMZIA(TM) -- the higher dose is not necessary. CIMZIA(TM) was also shown to have a rapid onset of action: in RAPID 1, a 25.4% ACR50 response rate was observed at week 8 in both treatment groups.

"These results are significant. They showed, for the first time, that the Fc region present in conventional anti-TNFs is not required
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
3. Gabapentin Shown Effective for Fibromyalgia Pain
4. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
5. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
6. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
7. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
8. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
9. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
10. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
11. In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., a ... the launch of their web site ( http://www.stephreports.com ... About STEPh Reports STEPh ... Each STEPh Report assesses the competitive ... projected launch year, company, and specific key issues.  STEPh ...
(Date:5/22/2013)... May 22, 2013   Upsher-Smith Laboratories, ... of its global Phase III clinical trial ... program for the management of epilepsy in ... USL255 is specifically engineered to provide convenient ... blood levels observed with currently available treatment ...
(Date:5/22/2013)... N.J. , May 22, 2013 MEDIFIRST ... opportunity to update shareholders about some recent company developments. ... expand its avenues of communication with shareholders. Integrating social ... launched a Facebook page and will post updates on ... Twitter hashtag is #medifirstusa. Says CEO ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Medifirst Solutions, Inc. Announces Update To Shareholders 2
... 30 Transgenomic, Inc. (OTC,Bulletin Board: TBIO), a ... National Cancer Institute had approved a proposal to,perform ... in,the NCI 60 cancer cell line panel., ... warning,signal in several different types of cancer. This ...
... Spherix Incorporated,(Nasdaq: SPEX ) announced today that it ... manufacturer of bulk pharmaceutical ingredients,to supply a portion of ... of the unique sugar as a treatment for Type ... Practice) production batches,of D- tagatose for the Spherix New ...
Cached Medicine Technology:Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 2Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 3Spherix D-tagatose to be Supplied by Inalco SpA 2
(Date:5/22/2013)... 2013 The Muscular Dystrophy Association scored ... at the annual Charlotte Muscle Team event held May ... families living with muscle disease. , "The Charlotte ... support MDA families,” said MDA Divisional Director Theresa Miller. ... with a "Buddy" to make their night extra special, ...
(Date:5/22/2013)... Dennis Thompson HealthDay Reporter , , WEDNESDAY, May ... or back pain are more likely to attempt suicide, ... another psychiatric condition, according to a new study. ... should be aware they are at increased risk of ... Affairs Serious Mental Illness Treatment Resource and Evaluation Center ...
(Date:5/22/2013)... 22, 2013 Diversity Focus and Handicap ... The performance promotes awareness that physical disabilities do ... This! performance will be held Friday, June 14th at ... Tickets for Handicap This! can be purchased at ... measure the level to which their mind is handicap ...
(Date:5/22/2013)... in genomic health disparities from the University of Miami ... of Medicine have teamed up to hold the second ... Disparities in Genomic Medicine." The theme of this ... and government to reduce these disparities. , Despite steady ... individuals within underserved groups continue to be more vulnerable ...
(Date:5/22/2013)... York (PRWEB) May 22, 2013 Phelps ... established the Westchester Lung Nodule Center for individuals ... receive lung cancer care. Lung cancer is the deadliest form ... more people in the U.S. die from lung cancer than ... with all cancers, early detection increases survival rates. It ...
Breaking Medicine News(10 mins):Health News:Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:Handicap This! Comes to Marion, Iowa 2Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3
... 4,000 people in the UK die each year from the effects of asbestos ... ... November 1999, the Government,s ban on the use of Asbestos came into force. ... die each year from the effects of asbestos exposure whilst at work. ...
... The Committee for Human,Medicinal Products (CHMP) ... once-daily dosing of 800 mg PREZISTA(R) (darunavir) ... in treatment-naive adults (those who,have never taken ... was,developed by Tibotec Pharmaceuticals, and Tibotec, a ...
... growth, experts say , , THURSDAY, Nov. 27 (HealthDay ... on your plate this Thanksgiving, because it may help protect ... Urological Association. , The high acid content in cranberries, ... simple UTIs, help inhibit bacterial growth along the urinary tract, ...
... 27 /PRNewswire-Asia-FirstCall/ -- China,s leading,integrated medical device and ... or "the Company", Stock Code: 8180.HK) is,pleased to ... in,Atlantis Investment Management Limited ("Atlantis Investment") as financial,investors ... shares at a price,HK$1.03 per share. , ...
... To coincide with Staying Alive,s tenth,anniversary on World AIDS ... of Travis McCoy, lead vocalist of the alternative,hip-hop band ... , Travis joins ... Beyonce, Mary J Blige, Justin Timberlake and Diddy, who ...
... healthcare services for seasonal vineyard workers and their families. In ... 2007 vintage. , ... Portland, OR (PRWEB) November 26, ... contributed generously to the 17th annual benefit with animated bidding on ...
Cached Medicine News:Health News:Nine Year Ban Fails to Eradicate Asbestos Related Diseases 2Health News:Nine Year Ban Fails to Eradicate Asbestos Related Diseases 3Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 2Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 3Health News:European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1 4Health News:Cranberries May Help Prevent Urinary Tract Infections 2Health News:Golden Meditech Brings in Financial Investor Through New Share Issuance 2Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 2Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 3Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 4Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 5Health News:On Staying Alive's 10th Anniversary, Gym Class Heroes Singer Travis McCoy Named 2009 Foundation Ambassador 6Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 2Health News:Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000 3
Stab incision blades color coded for simple and accurate identification...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
Medicine Products: